Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype

Objective To evaluate the association between androstenedione, testosterone, and free testosterone and metabolic disturbances in polycystic ovary syndrome. Methods We analyzed the association between androstenedione, testosterone, and free testosterone and metabolic parameters in a cross-sectional s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lerchbaum, Elisabeth (VerfasserIn) , Schwetz, Verena (VerfasserIn) , Rabe, Thomas (VerfasserIn) , Giuliani, Albrecht (VerfasserIn) , Obermayer-Pietsch, Barbara (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 13, 2014
In: PLOS ONE
Year: 2014, Jahrgang: 9, Heft: 10
ISSN:1932-6203
DOI:10.1371/journal.pone.0108263
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1371/journal.pone.0108263
Verlag, lizenzpflichtig, Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108263
Volltext
Verfasserangaben:Elisabeth Lerchbaum, Verena Schwetz, Thomas Rabe, Albrecht Giuliani, Barbara Obermayer-Pietsch

MARC

LEADER 00000caa a2200000 c 4500
001 1724485377
003 DE-627
005 20220818145508.0
007 cr uuu---uuuuu
008 200713s2014 xx |||||o 00| ||eng c
024 7 |a 10.1371/journal.pone.0108263  |2 doi 
035 |a (DE-627)1724485377 
035 |a (DE-599)KXP1724485377 
035 |a (OCoLC)1341345280 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lerchbaum, Elisabeth  |e VerfasserIn  |0 (DE-588)1068937459  |0 (DE-627)821074288  |0 (DE-576)428312543  |4 aut 
245 1 0 |a Hyperandrogenemia in polycystic ovary syndrome  |b exploration of the role of free testosterone and androstenedione in metabolic phenotype  |c Elisabeth Lerchbaum, Verena Schwetz, Thomas Rabe, Albrecht Giuliani, Barbara Obermayer-Pietsch 
264 1 |c October 13, 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.07.2020 
520 |a Objective To evaluate the association between androstenedione, testosterone, and free testosterone and metabolic disturbances in polycystic ovary syndrome. Methods We analyzed the association between androstenedione, testosterone, and free testosterone and metabolic parameters in a cross-sectional study including 706 polycystic ovary syndrome and 140 BMI-matched healthy women. Polycystic ovary syndrome women were categorized into 4 groups: normal androstenedione and normal free testosterone (NA/NFT), elevated androstenedione and normal free testosterone (HA/NFT), normal androstenedione and elevated free testosterone (NA/HFT), elevated androstenedione and free testosterone (HA/HFT). Results Polycystic ovary syndrome women with elevated free testosterone levels (HA/HFT and NA/HFT) have an adverse metabolic profile including 2 h glucose, HbA1c, fasting and 2 h insulin, area under the insulin response curve, insulin resistance, insulin sensitivity index (Matsuda), triglycerides, total and high density lipoprotein cholesterol levels compared to NA/NFT (p<0.05 for all age- and BMI-adjusted analyses). In binary logistic regression analysis adjusted for age and BMI, odds ratio for insulin resistance was 2.78 (1.34-5.75, p = 0.006) for polycystic ovary syndrome women with HA/HFT compared to NA/NFT. We found no significantly increased risk of metabolic disorders in polycystic ovary syndrome women with HA/NFT. In multiple linear regression analyses (age- and BMI-adjusted), we found a significant negative association between androstenedione/free testosterone-ratio and area under the insulin response curve, insulin resistance, and total cholesterol/high density lipoprotein cholesterol-ratio and a positive association with Matsuda-index, and high density lipoprotein cholesterol (p<0.05 for all). Conclusions Polycystic ovary syndrome women with elevated free testosterone levels but not with isolated androstenedione elevation have an adverse metabolic phenotype. Further, a higher androstenedione/free testosterone-ratio was independently associated with a beneficial metabolic profile. 
650 4 |a Androgens 
650 4 |a Cholesterol 
650 4 |a Glucose metabolism 
650 4 |a Insulin 
650 4 |a Insulin resistance 
650 4 |a Polycystic ovary syndrome 
650 4 |a Regression analysis 
650 4 |a Testosterone 
700 1 |a Schwetz, Verena  |e VerfasserIn  |4 aut 
700 1 |a Rabe, Thomas  |d 1951-  |e VerfasserIn  |0 (DE-588)120341654  |0 (DE-627)080614795  |0 (DE-576)166163465  |4 aut 
700 1 |a Giuliani, Albrecht  |e VerfasserIn  |4 aut 
700 1 |a Obermayer-Pietsch, Barbara  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t PLOS ONE  |d San Francisco, California, US : PLOS, 2006  |g 9(2014,10) Artikel-Nummer e108263, 12 Seiten  |h Online-Ressource  |w (DE-627)523574592  |w (DE-600)2267670-3  |w (DE-576)281331979  |x 1932-6203  |7 nnas  |a Hyperandrogenemia in polycystic ovary syndrome exploration of the role of free testosterone and androstenedione in metabolic phenotype 
773 1 8 |g volume:9  |g year:2014  |g number:10  |a Hyperandrogenemia in polycystic ovary syndrome exploration of the role of free testosterone and androstenedione in metabolic phenotype 
856 4 0 |u https://doi.org/10.1371/journal.pone.0108263  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108263  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200713 
993 |a Article 
994 |a 2014 
998 |g 120341654  |a Rabe, Thomas  |m 120341654:Rabe, Thomas  |d 910000  |d 910400  |e 910000PR120341654  |e 910400PR120341654  |k 0/910000/  |k 1/910000/910400/  |p 3 
998 |g 1068937459  |a Lerchbaum, Elisabeth  |m 1068937459:Lerchbaum, Elisabeth  |p 1  |x j 
999 |a KXP-PPN1724485377  |e 3723960847 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"relHost":[{"part":{"volume":"9","text":"9(2014,10) Artikel-Nummer e108263, 12 Seiten","year":"2014","issue":"10"},"pubHistory":["1.2006 -"],"language":["eng"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"Public Library of Science","role":"isb"}],"recId":"523574592","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Hyperandrogenemia in polycystic ovary syndrome exploration of the role of free testosterone and androstenedione in metabolic phenotypePLOS ONE","note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"title":[{"title_sort":"PLOS ONE","title":"PLOS ONE"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1932-6203"],"eki":["523574592"],"zdb":["2267670-3"]},"origin":[{"publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","publisher":"PLOS ; PLoS","dateIssuedKey":"2006","dateIssuedDisp":"2006-"}],"name":{"displayForm":["Public Library of Science"]}}],"recId":"1724485377","note":["Gesehen am 13.07.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1371/journal.pone.0108263"],"eki":["1724485377"]},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"October 13, 2014"}],"title":[{"title_sort":"Hyperandrogenemia in polycystic ovary syndrome","title":"Hyperandrogenemia in polycystic ovary syndrome","subtitle":"exploration of the role of free testosterone and androstenedione in metabolic phenotype"}],"name":{"displayForm":["Elisabeth Lerchbaum, Verena Schwetz, Thomas Rabe, Albrecht Giuliani, Barbara Obermayer-Pietsch"]},"person":[{"given":"Elisabeth","family":"Lerchbaum","role":"aut","roleDisplay":"VerfasserIn","display":"Lerchbaum, Elisabeth"},{"given":"Verena","family":"Schwetz","role":"aut","display":"Schwetz, Verena","roleDisplay":"VerfasserIn"},{"given":"Thomas","family":"Rabe","role":"aut","display":"Rabe, Thomas","roleDisplay":"VerfasserIn"},{"family":"Giuliani","given":"Albrecht","display":"Giuliani, Albrecht","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Barbara","family":"Obermayer-Pietsch","role":"aut","roleDisplay":"VerfasserIn","display":"Obermayer-Pietsch, Barbara"}]} 
SRT |a LERCHBAUMEHYPERANDRO1320